HIBL - Daily S&P 500 High Beta Bull 3X Shares
| Assets | $145.13M |
| NAV | $68.64 |
| Expense Ratio | 1.03% |
| PE Ratio | n/a |
| Beta (5Y) | 4.90 |
| Dividend (ttm) | $0.04 |
| Dividend Yield | 0.06% |
| Ex-Dividend Date | Jun 22, 2021 |
| 1-Year Return | - |
| Trading Day | July 23 |
| Last Price | $59.28 |
| Previous Close | $59.23 |
| Change ($) | 0.05 |
| Change (%) | 0.08% |
| Day's Open | 60.03 |
| Day's Range | 58.02 - 60.37 |
| Day's Volume | 157,701 |
| 52-Week Range | 11.90 - 79.72 |
Fund Description
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P 500® High Beta Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index provider selects 100 securities to include in the index from the S&P 500® Index that have the highest sensitivity to market movements, or beta over the past 12 months as determined by the index provider. It is non-diversified.
| Asset Class Equity | Inception Date Nov 7, 2019 |
| Exchange NYSEARCA | Ticker Symbol HIBL |
| Index Tracked SP 500 High Beta Index | |
Top 10 Holdings
80.45% of assets| Name | Symbol | Weight |
|---|---|---|
| S&P 500 HIGH BETA INDEX SWAP | n/a | 40.37% |
| S&P 500 HIGH BETA INDEX SWAP | n/a | 16.88% |
| S&P 500 HIGH BETA INDEX SWAP | n/a | 10.12% |
| BANK OF NEW YORK CASH RESERVE | n/a | 5.68% |
| S&P 500 HIGH BETA INDEX SWAP | n/a | 3.25% |
| GOLDMAN FS GOVT INST | n/a | 2.75% |
| GOLDMAN FINL SQ TRSRY INST 506 | n/a | 0.39% |
| DREYFUS GOVT CASH MGMT | n/a | 0.36% |
| DREYFUS GOVT CASH MGMT | n/a | 0.35% |
| Enphase Energy | ENPH | 0.30% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 22, 2021 | $0.036 | Jun 29, 2021 |
| Mar 23, 2021 | $0.006 | Mar 30, 2021 |
| Mar 24, 2020 | $0.428 | Mar 31, 2020 |
| Dec 23, 2019 | $0.059 | Dec 31, 2019 |
Wall Street started the week on a shaky note due to a spike in U.S. COVID cases, which is a potential threat to economic reopening.
We highlight a bunch of the best-performing leveraged equity ETFs from the different corners of the market that piled up more than 60% gains in the first half of 2021.
More investors are exiting risky stocks and entering ETFs. One way to play the exodus is the Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL).
Wall Street was muted last week with the S&P 500 gaining 0.02% but the Dow Jones, the Nasdaq Composite and the Russell 2000 showing a downtrend.
The combination of rapid COVID-19 vaccinations, progress on vaccines, and an unprecedented stimulus have been the major catalysts.
Given the momentum of the previous 12 months and the fact that the threat of COVID-19 has seemingly begun to recede in many parts of the world, including the U.S., traders may have been hoping 2021 woul...
It appears the markets shook off last week's inflation fears as the major indexes saw green in Monday's trading session. The Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL) notched a 7% gain and ...
Renewed optimism over speedy economic recovery from the pandemic-driven recession kept the bullish run intact.
Last week was quite a lull for Wall Street. A jump in U.S. treasury yields can be held responsible for the broader market underperformance.
Also, the Select Sector SPDRs had their expense ratios lowered by 1 basis point.
We highlight some leveraged ETFs that gained more than 85% over the past three months.
For the average ETF investor, high volatility from a high beta fund might not fall in the ideal risk tolerance range. Nonetheless, for the leverage-hungry trader, ETFs like the Direxion Daily S&P 500 Hi...
The S&P 500, the Dow Jones and the Nasdaq Composite gained about 1.7%, 1.0% and 2.1%, respectively, last week.
The solid fundamentals and a soaring stock market have resulted in huge demand for the leveraged ETFs.
As the anticipation of a COVID-19 vaccine grows, positivity is giving the capital markets a boost, but as sellers start to do their profit-taking the markets should dip, adding another dose of volatilit...
Last week was all about vaccine hopes and a stupendous Wall Street rally.
Wall Street spiked on Nov 9 on news that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial.
The S&P 500, the Dow Jones and the Nasdaq Composite lost about 0.5%, 1% and 1.1%, respectively, in the past week.
The U.S. stock market extended its bull rally to start the month of June with surprisingly upbeat job data.
U.S. stocks came back roaring in April buoyed by unprecedented fiscal and monetary stimulus, progress in the development of a coronavirus vaccine or treatment as well as optimism over the reopening of t...
Inside the top-and-worst-performing leveraged ETFs of last week.
Direxion recently launched the Direxion Daily S&P 500® High Beta Bull and Bear 3X Shares – HIBL and HIBS.